Projects per year
Personal profile
Education
- 2007-2013 Ph.D., The Institute of Basic Medical Sciences, National Cheng Kung University
- 2004-2006 M.S., Institute of Biomedical Research, National Sun Yat-sen University
- 2000-2004 B.S., Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University
Experience
- 2019.08- Assistant Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2015.03-2019.08 Postdoctoral Research Fellow, Molecular and Cell Biology, Baylor College of Medicine
Fingerprint
Dive into the research topics where Yu-Cheng Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Study of Extracellular Matrix Collagens-Driven Acidic Microenvironment Confers Malignant Properties in Bladder Tumors (2/2)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
研究以糖解作用酵素Enolase-1作為標的，抑制膀胱癌細胞轉移及其調控機制的探討
7/1/22 → 2/28/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討E3泛素化連接酶(WWP2)對於調控盤狀結構域接受器(DDR1)的蛋白穩定性進而影響細胞增殖、遷移能力之可能性
7/1/22 → 2/28/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
Study of Extracellular Matrix Collagens-Driven Acidic Microenvironment Confers Malignant Properties in Bladder Tumors
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討DDR1透過Galectin-3促進膀胱癌增殖與遷移之可能性
7/1/21 → 2/28/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
Evaluating the pharmacotherapy of tirzepatide in patients with type 2 diabetes: The consideration of systemic metabolism
Lee, Y. C. & Chung, H. H., Mar 2023, In: British Journal of Clinical Pharmacology. 89, 3, p. 1222-1223 2 p.Research output: Contribution to journal › Letter › peer-review
-
Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma
Lee, Y. C., Lin, C. H., Chang, W. L., Lin, W. D., Pan, J. K., Wang, W. J., Su, B. C., Chung, H. H., Tsai, C. H., Lin, F. C., Wang, W. C. & Lu, P. J., Apr 1 2022, In: International journal of molecular sciences. 23, 8, 4367.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Development of a novel latent electrochemical molecular substrate for the real-time monitoring of the tumor marker aminopeptidase N in live cells, whole blood and urine
Kumaravel, S., Luo, G. R., Huang, S. T., Lin, H. Y., Lin, C. M. & Lee, Y. C., May 1 2022, In: Biosensors and Bioelectronics. 203, 114049.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy
You, S., Kim, M., Hoi, X. P., Lee, Y. C., Wang, L., Spetzler, D., Abraham, J., Magee, D., Jain, P., Galsky, M. D., Chan, K. S. & Theodorescu, D., Oct 6 2022, In: Journal of the National Cancer Institute. 114, 10, p. 1380-1391 12 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Hedgehog Suppresses Paclitaxel Sensitivity by Regulating Akt-Mediated Phosphorylation of Bax in EGFR Wild-Type Non-Small Cell Lung Cancer Cells
Tu, Y. C., Yeh, W. C., Yu, H. H., Lee, Y. C. & Su, B. C., Feb 18 2022, In: Frontiers in Pharmacology. 13, 815308.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)